Vascular disease

First Australian snapshot of CTEPH reveals opportunities for better care

Australia’s first major snapshot into chronic thromboembolic pulmonary hypertension (CTEPH) shows long-term survival rates are on par with international outcomes, but greater access to and awareness of treatment options are needed to optimise care. A review of the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) registry explored outcomes for 386 patients diagnosed with ...

Already a member?

Login to keep reading.

© 2021 the limbic